{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:56:28Z","timestamp":1791453388780,"version":"4.3.3"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cld.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:16:27Z","timestamp":1747034187000},"page":"371-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amyloidosis and the Liver"],"prefix":"10.1016","volume":"29","author":[{"given":"Rama","family":"Tarakji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar","year":"2021","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.cld.2025.03.007_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/MEG.0000000000000695","article-title":"Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management","volume":"28","author":"Syed","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cld.2025.03.007_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park","year":"2003","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.cld.2025.03.007_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4254\/wjh.v8.i6.340","article-title":"Primary hepatic amyloidosis: a case report and review of literature","volume":"8","author":"Sonthalia","year":"2016","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0000000000000695","article-title":"Diagnosis of amyloid beyond Congo red","volume":"30","author":"Picken","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5858\/arpa.2018-0509-RA","article-title":"An organ system\u2013based approach to differential diagnosis of amyloid type in surgical pathology","volume":"144","author":"Giannini","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"10.1016\/j.cld.2025.03.007_bib9","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2016-01-629790","article-title":"What is new in diagnosis and management of light chain amyloidosis?","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cld.2025.03.007_bib11","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1093\/annonc\/mdn200","article-title":"Amyloidosis: is a cure possible?","volume":"19","author":"Merlini","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4065\/mcp.2010.0480","article-title":"Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score","volume":"86","author":"Kumar","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term Follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14797\/mdcvj.1070","article-title":"Light chain amyloidosis: epidemiology, staging, and prognostication","volume":"18","author":"Baker","year":"2022","journal-title":"Methodist DeBakey Cardiovasc J"},{"issue":"14","key":"10.1016\/j.cld.2025.03.007_bib15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options","volume":"29","author":"Merlini","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.cld.2025.03.007_bib16","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","article-title":"High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly","volume":"42","author":"Sekijima","year":"2011","journal-title":"Hum Pathol"},{"issue":"10038","key":"10.1016\/j.cld.2025.03.007_bib17","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cld.2025.03.007_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.cld.2025.03.007_bib19","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"issue":"82","key":"10.1016\/j.cld.2025.03.007_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev-biochem-072611-130030","article-title":"Systemic amyloidoses","volume":"82","author":"Blancas-Mej\u00eda","year":"2013","journal-title":"Annu Rev Biochem"},{"issue":"23","key":"10.1016\/j.cld.2025.03.007_bib21","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib22","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0016-5085(97)70150-1","article-title":"Long-term survival in systemic amyloid A amyloidosis complicating Crohn\u2019s disease","volume":"112","author":"Lovat","year":"1997","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2025.03.007_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/41.7.833","article-title":"Treatment of AA amyloid with chlorambucil","volume":"41","author":"Ortiz-Santamar\u00eda","year":"2002","journal-title":"Rheumatol Oxf Engl"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000186801","article-title":"Colchicine prevents kidney transplant amyloidosis in familial mediterranean fever","volume":"60","author":"Livneh","year":"1992","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13506129.2017.1352503","article-title":"Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cts.12469","article-title":"Leukocyte cell-derived Chemotaxin-2: it\u2019s role in pathophysiology and future in clinical medicine","volume":"10","author":"Slowik","year":"2017","journal-title":"Clin Transl Sci"},{"issue":"10","key":"10.1016\/j.cld.2025.03.007_bib27","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)\u2013Associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2014.11","article-title":"Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.cld.2025.03.007_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/0046-8177(91)90180-W","article-title":"Hepatic amyloidosis: morphologic differences between systemic AL and AA types","volume":"22","author":"Buck","year":"1991","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/PAS.0000000000000373","article-title":"Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis","volume":"39","author":"Chandan","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1016\/j.cld.2025.03.007_bib33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1665-2681(19)31450-4","article-title":"Primary hepatic amyloidosis: a mini literature review and five cases report","volume":"11","author":"Wang","year":"2012","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0002-9343(62)90231-0","article-title":"Amyloid disease of the liver: correlation of clinical, functional and morphologic features in forty-seven patients","volume":"33","author":"Levine","year":"1962","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.32.2.227","article-title":"Sinusoidal portal hypertension in hepatic amyloidosis","volume":"32","author":"Bion","year":"1991","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib36","first-page":"201","article-title":"Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension","volume":"16","author":"Culafi\u0107","year":"2007","journal-title":"J Gastrointest Liver Dis JGLD"},{"key":"10.1016\/j.cld.2025.03.007_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222942","article-title":"Hepatic amyloidosis: a cause of rapidly progressive jaundice","author":"Ford","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"12","key":"10.1016\/j.cld.2025.03.007_bib38","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000479","article-title":"Amyloidosis: a rare cause of severe cholestasis and acute liver failure","volume":"7","author":"Kim","year":"2020","journal-title":"ACG Case Rep J"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib39","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000999","article-title":"Hepatic amyloidosis with multiorgan involvement","volume":"10","author":"Duve","year":"2023","journal-title":"ACG Case Rep J"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12876-022-02201-4","article-title":"AL amyloidosis with primary presentation of multiple serous cavity effusion and severe cholestasis: a case report and review of literature","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2025.03.007_bib41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.prp.2012.07.011","article-title":"Hepatic amyloidosis: morphologic spectrum of histopathological changes in AA and nonAA amyloidosis","volume":"208","author":"Sarsik","year":"2012","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-197507000-00001","article-title":"Amyloidosis: review of 236 cases","volume":"54","author":"Kyle","year":"1975","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.cld.2025.03.007_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/hepr.12034","article-title":"Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitis","volume":"43","author":"Hirano","year":"2013","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gande.2022.11.003","article-title":"Hepatic amyloidosis accompanied with massive ascites and kidney impairment: a case report","volume":"1","author":"Lu","year":"2023","journal-title":"Gastroenterol Endosc"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1309\/AJCPCLK54RKXTRDI","article-title":"Hepatic ALECT-2 amyloidosis causing portal hypertension and recurrent variceal bleeding: a case report and review of the literature","volume":"141","author":"Damlaj","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"14","key":"10.1016\/j.cld.2025.03.007_bib46","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM198104023041407","article-title":"Mechanism of factor X deficiency in systemic amyloidosis","volume":"304","author":"Furie","year":"1981","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.cld.2025.03.007_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232448","article-title":"Spontaneous hepatic rupture due to primary amyloidosis","volume":"12","author":"Leonard-Murali","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cld.2025.03.007_bib48","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.933241","article-title":"Hepatic AL amyloidosis without significant light chain elevation in a patient treated with CyBorD plus daratumumab","volume":"22","author":"Rybinski","year":"2021","journal-title":"Am J Case Rep"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13506120902879574","article-title":"Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review","volume":"16","author":"Tam","year":"2009","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6060(96)80251-0","article-title":"Spontaneous liver rupture in amyloidosis","volume":"120","author":"Ooi","year":"1996","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/gut.38.1.151","article-title":"\u201cFragile\u201d liver and massive hepatic haemorrhage due to hereditary amyloidosis","volume":"38","author":"Harrison","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cld.2025.03.007_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/2156-7514.190859","article-title":"Post biopsy liver hemorrhage successfully controlled by ultrasound-guided percutaneous microwave ablation","volume":"6","author":"Wai","year":"2016","journal-title":"J Clin Imaging Sci"},{"key":"10.1016\/j.cld.2025.03.007_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109399","article-title":"Safety of percutaneous versus transjugular liver biopsy: a propensity score matched analysis","volume":"133","author":"Lavian","year":"2020","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.cld.2025.03.007_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/jcm8050739","article-title":"Magnetic resonance elastography of liver in light chain amyloidosis","volume":"8","author":"Venkatesh","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.cld.2025.03.007_bib55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gut.42.5.727","article-title":"The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients","volume":"42","author":"Lovat","year":"1998","journal-title":"Gut"},{"issue":"8853","key":"10.1016\/j.cld.2025.03.007_bib56","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","article-title":"Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis","volume":"341","author":"Holmgren","year":"1993","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the AASLD and the American society of transplantation","volume":"59","author":"Martin","year":"2013","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2025.03.007_bib58","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000508262","article-title":"Solid organ transplantation in amyloidosis","volume":"143","author":"Theodorakakou","year":"2020","journal-title":"Acta Haematol"},{"issue":"29","key":"10.1016\/j.cld.2025.03.007_bib60","doi-asserted-by":"crossref","first-page":"E6741","DOI":"10.1073\/pnas.1805131115","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Saelices","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cld.2025.03.007_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cardiogenetics11010002","article-title":"Cardiac amyloidosis therapy: a systematic review","volume":"11","author":"Iodice","year":"2021","journal-title":"Cardiogenetics"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2025.03.007_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231191590","article-title":"A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis","volume":"16","author":"Casasnovas","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1432-2277.2008.00737.x","article-title":"High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy: early thrombotic complications in liver transplantation","volume":"22","author":"Bispo","year":"2009","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.cld.2025.03.007_bib65","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2022.04.023","article-title":"Trends and outcomes of patients with amyloid cardiomyopathy listed for heart transplantation","volume":"38","author":"Akintoye","year":"2022","journal-title":"Can J Cardiol"},{"issue":"11","key":"10.1016\/j.cld.2025.03.007_bib66","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2024.02.1181","article-title":"Combined heart-liver transplant versus isolated heart or liver transplant in amyloidosis","volume":"43","author":"Song","year":"2024","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2025.03.007_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13506129.2011.574354071","article-title":"Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment","volume":"18","author":"Lobato","year":"2011","journal-title":"Amyloid"},{"issue":"12","key":"10.1016\/j.cld.2025.03.007_bib69","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/lt.22174","article-title":"Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation","volume":"16","author":"Llad\u00f3","year":"2010","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.cld.2025.03.007_bib70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.cld.2025.03.007_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/13506129.2023.2177986","article-title":"Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis","volume":"30","author":"Socie","year":"2023","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.cld.2025.03.007_bib72","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/ajt.17009","article-title":"Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation","volume":"22","author":"Schmidt","year":"2022","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib73","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/13506129.2020.1784134","article-title":"TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients","volume":"27","author":"Moshe-Lilie","year":"2020","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.cld.2025.03.007_bib74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.TP.0000046526.10003.EC","article-title":"Orthotopic liver transplantation for hereditary fibrinogen amyloidosis","volume":"75","author":"Zeldenrust","year":"2003","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2025.03.007_bib75","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2010.03227.x","article-title":"Solid organ transplantation in AL amyloidosis","volume":"10","author":"Sattianayagam","year":"2010","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2025.03.007_bib76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajt.16324","article-title":"Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: a consensus expert opinion statement","volume":"21","author":"Al-Adra","year":"2021","journal-title":"Am J Transplant"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326125000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:29:19Z","timestamp":1752676159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326125000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1089326125000236"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2025.03.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis and the Liver","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}